Market Tracker

12/05 1:37pm ET

Array Biopharma Inc (NASDAQ:ARRY)

8.61
BATS BZX Real-Time Price
As of 1:37pm ET
 +0.40 / +4.87%
Today’s Change
2.38
Today|||52-Week Range
8.68
+104.03%
Year-to-Date
Why Array BioPharma Rose 32.5% in November
Dec 03 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.21
Today’s open8.20
Day’s range8.19 - 8.68
Volume237,933
Average volume (3 months)5,491,502
Market cap$1.4B
Dividend yield--
Data as of 1:37pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-18.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.76+2.11%
AXONAxovant Sciences Ltd+0.50+3.70%
PBYIPuma Biotechnology I...+1.35+3.38%
AERIAerie Pharmaceutical...+1.65+4.29%
Data as of 1:36pm ET, 12/05/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts